Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Dyslipidemia treatment is of major importance in reducing the risk of atherosclerotic cardiovascular disease (ASCVD), which is still the most common cause of death worldwide. During the last decade, a novel lipid-lowering drug category has emerged, i.e., proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Apart from the two available...
Alternative Titles
Full title
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4fc927d3b68b4dbb931c05e71e9b4a55
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4fc927d3b68b4dbb931c05e71e9b4a55
Other Identifiers
ISSN
1424-8247
E-ISSN
1424-8247
DOI
10.3390/ph16040577
